Bank of Nova Scotia’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,085
| Closed | -$2.97M | – | 1045 |
|
|
2024
Q1 | $2.97M | Sell |
34,085
-1,527
| -4% | -$130K | 0.01% | 596 |
|
|
2023
Q4 | $2.93M | Sell |
35,612
-643
| -2% | -$49K | 0.01% | 591 |
|
|
2023
Q3 | $2.84M | Sell |
36,255
-2,531
| -7% | -$212K | 0.01% | 513 |
|
|
2023
Q2 | $3.42M | Sell |
38,786
-311
| -0.8% | -$26.8K | 0.01% | 427 |
|
|
2023
Q1 | $3.15M | Sell |
39,097
-235
| -0.6% | -$19.2K | 0.01% | 453 |
|
|
2022
Q4 | $3.06M | Buy |
39,332
+729
| +2% | +$59.1K | 0.01% | 558 |
|
|
2022
Q3 | $3.12M | Sell |
38,603
-688
| -2% | -$61.8K | 0.01% | 534 |
|
|
2022
Q2 | $3.53M | Sell |
39,291
-89
| -0.2% | -$9.02K | 0.01% | 565 |
|
|
2022
Q1 | $4.37M | Buy |
39,380
+353
| +0.9% | +$37.3K | 0.01% | 624 |
|
|
2021
Q4 | $4.04M | Sell |
39,027
-2,482
| -6% | -$287K | 0.01% | 742 |
|
|
2021
Q3 | $5.2M | Sell |
41,509
-525
| -1% | -$68K | 0.01% | 625 |
|
|
2021
Q2 | $5.22M | Buy |
42,034
+841
| +2% | +$106K | 0.01% | 589 |
|
|
2021
Q1 | $4.87M | Sell |
41,193
-41
| -0.1% | -$4.8K | 0.01% | 576 |
|
|
2020
Q4 | $4.83M | Buy |
41,234
+3,731
| +10% | +$411K | 0.01% | 512 |
|
|
2020
Q3 | $3.9M | Sell |
37,503
-272,150
| -88% | -$27.3M | 0.01% | 504 |
|
|
2020
Q2 | $28.4M | Buy |
309,653
+272,512
| +734% | +$26.1M | 0.1% | 176 |
|
|
2020
Q1 | $3.35M | Sell |
37,141
-649,369
| -95% | -$69.1M | 0.01% | 483 |
|
|
2019
Q4 | $77.9M | Buy |
686,510
+648,957
| +1,728% | +$71.2M | 0.19% | 122 |
|
|
2019
Q3 | $4.08M | Sell |
37,553
-1,154,080
| -97% | -$120M | 0.01% | 523 |
|
|
2019
Q2 | $115M | Sell |
1,191,633
-72,090
| -6% | -$6.58M | 0.48% | 51 |
|
|
2019
Q1 | $115M | Sell |
1,263,723
-274,040
| -18% | -$24.5M | 0.46% | 51 |
|
|
2018
Q4 | $140M | Buy |
1,537,763
+742,122
| +93% | +$69.4M | 0.65% | 34 |
|
|
2018
Q3 | $78.3M | Buy |
795,641
+457,130
| +135% | +$42.3M | 0.35% | 64 |
|
|
2018
Q2 | $29M | Buy |
338,511
+91,481
| +37% | +$7.64M | 0.16% | 126 |
|
|
2018
Q1 | $19.8M | Sell |
247,030
-209,048
| -46% | -$17.2M | 0.1% | 189 |
|
|
2017
Q4 | $36.8M | Buy |
456,078
+220,534
| +94% | +$17.7M | 0.17% | 130 |
|
|
2017
Q3 | $18.3M | Sell |
235,544
-473,318
| -67% | -$39.3M | 0.11% | 178 |
|
|
2017
Q2 | $62.9M | Sell |
708,862
-4,486
| -0.6% | -$378K | 0.33% | 62 |
|
|
2017
Q1 | $57.5M | Buy |
713,348
+282,569
| +66% | +$22.1M | 0.25% | 84 |
|
|
2016
Q4 | $30.7M | Buy |
430,779
+282,195
| +190% | +$22.2M | 0.16% | 92 |
|
|
2016
Q3 | $12.8M | Sell |
148,584
-17,339
| -10% | -$1.51M | 0.07% | 138 |
|
|
2016
Q2 | $14.4M | Buy |
165,923
+139,400
| +526% | +$11.3M | 0.08% | 121 |
|
|
2016
Q1 | $1.99M | Buy |
26,523
+260
| +1% | +$19.6K | 0.01% | 301 |
|
|
2015
Q4 | $2.02M | Sell |
26,263
-179
| -0.7% | -$13.5K | 0.01% | 337 |
|
|
2015
Q3 | $1.77M | Buy |
26,442
+896
| +4% | +$66K | 0.01% | 275 |
|
|
2015
Q2 | $1.89M | Buy |
25,546
+1,120
| +5% | +$85.6K | 0.01% | 234 |
|
|
2015
Q1 | $1.91M | Sell |
24,426
-313,599
| -93% | -$23.8M | 0.01% | 235 |
|
|
2014
Q4 | $24.4M | Buy |
338,025
+321,565
| +1,954% | +$22.3M | 0.09% | 103 |
|
|
2014
Q3 | $1.02M | Buy |
16,460
+690
| +4% | +$43.9K | ﹤0.01% | 283 |
|
|
2014
Q2 | $1M | Buy |
15,770
+830
| +6% | +$50.4K | ﹤0.01% | 282 |
|
|
2014
Q1 | $919K | Buy |
14,940
+1,048
| +8% | +$61K | ﹤0.01% | 310 |
|
|
2013
Q4 | $797K | Buy |
13,892
+338
| +2% | +$19.2K | ﹤0.01% | 333 |
|
|
2013
Q3 | $721K | Sell |
13,554
-182
| -1% | -$9.79K | ﹤0.01% | 302 |
|
|
2013
Q2 | $707K | Buy |
+13,736
| New | +$679K | ﹤0.01% | 277 |
|
Other funds holding MDT
Bank of Nova Scotia's MDT Position: Q2 2024 in Review
Bank of Nova Scotia sold out of Medtronic (MDT) in Q2 2024, closing a stake of 34,085 shares — an estimated $2.97M sold.
Bank of Nova Scotia first reported a position in MDT in Q2 2013 and held it in 44 quarters. The position peaked at $140M in Q4 2018. 2,024 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Bank of Nova Scotia reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
- Bank of Nova Scotia sold 34,085 Medtronic shares in Q2 2024, an estimated $2.97M.
- Bank of Nova Scotia first reported a position in Medtronic in Q2 2013 and held it in 44 quarters.
- Bank of Nova Scotia's Medtronic position peaked at $140M in Q4 2018.
- 2,024 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Bank of Nova Scotia's 13F filing for Q2 2024, filed 14 Aug 2024.